Michael Kaplan
Lawyers
Filters
International Flavors & Fragrances Inc. $1.5 Billion Senior Notes Offering
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by International Flavors & Fragrances Inc. of $1.5 billion aggregate…
International Flavors & Fragrances Inc. €1.1 Billion Senior Notes Offering
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by International Flavors & Fragrances Inc. of €1.1 billion aggregate principal…
International Flavors & Fragrances Inc. $1.65 Billion Common Stock Offering and $825 Million Tangible Equity Units Offering
Davis Polk advised the representatives of the underwriters in connection with a $1.65 billion SEC-registered offering of 12,667,947 shares of common stock (which included 1,151,632 shares…
Davis Polk Advises Aptiv on Its Acquisition of Winchester Interconnect
Davis Polk is advising Aptiv PLC on its acquisition of Winchester Interconnect from an affiliate of Snow Phipps Group for $650 million. The transaction is subject to regulatory approval and…
Energizer Gamma Acquisition, Inc. $500 Million Notes Offering and Energizer Gamma Acquisition B.V. €650 Million Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Energizer Gamma Acquisition, Inc. of $500 million aggregate principal amount of its 6.375%…
Century Communities, Inc. $100 Million SEC-Registered At-The-Market Offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Century Communities, Inc. of its shares of common stock for up to an aggregate amount…
Davis Polk Advises Entera Bio Ltd. on Its Initial Public Offering
Davis Polk advised Entera Bio Ltd. on its initial public offering of 1,400,000 ordinary shares and 1,400,000 warrants to purchase up to 700,000 ordinary shares. In addition, Entera Bio Ltd…
Davis Polk Advises Kadmon Holdings, Inc. on Its Follow-on Offering of Common Stock
Davis Polk advised Kadmon Holdings, Inc. in connection with a $113.2 million offering of 32,022,728 shares of common stock, which included the full exercise of the underwriters’ option to…
Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $2.05 Billion Refinancing
Davis Polk advised Valeant Pharmaceuticals International, Inc. in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant Pharmaceuticals…
Davis Polk Advises Israel Chemicals Limited on Its $600 Million Senior Notes Offering and Concurrent Tender Offer
Davis Polk advised Israel Chemicals Limited in connection with its 144A/Regulation S notes offering of $600 million aggregate principal amount of 6.375% senior notes due 2038.
Davis…